Fig. 5.
Fig. 5. Increase in the percentage of CD44hi T lymphocytes in the CD4+ and CD8+ T cells from spleens and lymph nodes of mice treated with CTX or poly (I:C). / Seven- to 8-week-old DBA/2 mice were injected intraperitoneally with CTX (83 mg/kg) (dotted bars), poly (I:C) (0.15 mg/mouse) (striped bars), or saline (white bars). At different time intervals, spleens and a pool of lymph nodes were taken and disaggregated. Cells were stained for CD44 and for CD4 or CD8 surface antigen expression before being processed for cytofluorimetric analysis. There were 3 mice per group. The data show the mean (± SE) value of the percentage of CD44hi cells on CD4 (left panels) or CD8 (right panels) lymphocytes, in the spleen (upper panels) or in the pooled lymph nodes (lower panels).

Increase in the percentage of CD44hi T lymphocytes in the CD4+ and CD8+ T cells from spleens and lymph nodes of mice treated with CTX or poly (I:C).

Seven- to 8-week-old DBA/2 mice were injected intraperitoneally with CTX (83 mg/kg) (dotted bars), poly (I:C) (0.15 mg/mouse) (striped bars), or saline (white bars). At different time intervals, spleens and a pool of lymph nodes were taken and disaggregated. Cells were stained for CD44 and for CD4 or CD8 surface antigen expression before being processed for cytofluorimetric analysis. There were 3 mice per group. The data show the mean (± SE) value of the percentage of CD44hi cells on CD4 (left panels) or CD8 (right panels) lymphocytes, in the spleen (upper panels) or in the pooled lymph nodes (lower panels).

Close Modal

or Create an Account

Close Modal
Close Modal